Endpoints News 2025-12-11 Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trial
Endpoints News 2025-12-11 AC Immune says early biomarker data are promising in Parkinson's, but clinical benefit remains unclear
Endpoints News 2025-12-11 Corbus’ obesity pill posts muted weight loss data; Disco adds another €16M in seed funding
Endpoints News 2025-12-11 Zealand inks deal with OTR Therapeutics as it spells out broader metabolic disease ambitions
Endpoints News 2025-12-11 Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO
Endpoints News 2025-12-11 Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported
Endpoints News 2025-12-10 Investors buy up stocks in biggest follow-on offering day in biotech history
Endpoints News 2025-12-10 Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backer
Endpoints News 2025-12-10 #SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%